To start our new Optometry section, editor Janet Pooley takes a look at the tragic death of Vincent Barker and asks what lessons can be learned. In August, Optometrist Honey Rose was found guilty of the manslaughter of eight-year-old Vincent...
“Please phone Mr C Lyon ASAP on 0131 334 9171” This was a message from my secretary waiting for me on my computer one morning shortly after I was appointed a consultant. The name did not ring any bells but...
A community of gamers with sight loss from across Scotland and Northern Ireland says its network is thriving as it marks its fifth anniversary. Formed during the pandemic lockdown in November 2020, as part of RNIB’s community work, the group...
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. #QueenElizabeth #cataract It is well and truly summer! Queen Elizabeth was spotted in her sunnies during recent events, not just...
The field of healthcare has a substantial impact on the environment as it is responsible for 5-10% of greenhouse gas emissions and 9% of air pollutant generation [1]. Surgery is associated with the rapid consumption of single-use products and waste...
As a specialist registrar training in Aberdeen there were two important lessons I learned which have proved to be invaluable over the years for two very different reasons. The first lesson learned was to never underestimate the wind chill factor...
The Vesalius Innovation Award, recognising excellence in science communication, has announced its jury members. This year marks a first in the award’s five-year history, as BMJ Group joins Karger Publishers to co-present the award. The Vesalius Innovation Award for innovation...
This is a fairly comprehensive textbook with 20 chapters covering the most common neuro-ophthalmic problems you are likely to encounter in clinical practice. The chapters each comprise several sections, the titles of which are often phrased as questions the reader...
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....
Six eyes with corneal vascularisation were treated with 1% topical doxycycline, four times a day for three weeks. The patients were reviewed at various intervals over a period of one year. The eyes selected had neovascularisation secondary to a variety...
Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...